Marksans Pharma Ltd MARKSANS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 1:06 PM IST
48.30quote price arrow down-1.05 (-2.13%)
Volume
3,158,520
52 week range
38.60 - 93.60
Loading...
  • Open49.65
  • Day High49.65
  • Day Low47.70
  • Prev Close49.35
  • 52 Week High93.60
  • 52 Week High Date07/06/21
  • 52 Week Low38.60
  • 52 Week Low Date06/20/22

Key Stats

  • Market Cap225.41M
  • Shares Out409.31M
  • 10 Day Average Volume2.97M
  • Dividend0.25
  • Dividend Yield0.52%
  • Beta-
  • YTD % Change-19.83

KEY STATS

  • Open49.65
  • Day High49.65
  • Day Low47.70
  • Prev Close49.35
  • 52 Week High93.60
  • 52 Week High Date07/06/21
  • 52 Week Low38.60
  • 52 Week Low Date06/20/22
  • Market Cap225.41M
  • Shares Out409.31M
  • 10 Day Average Volume2.97M
  • Dividend0.25
  • Dividend Yield0.52%
  • Beta-
  • YTD % Change-19.83

RATIOS/PROFITABILITY

  • EPS (TTM)4.51
  • P/E (TTM)10.71
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/15/2021
  • Div Amount0.25
  • Split Date-
  • Split Factor-

Latest On Marksans Pharma Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Marksans Pharma Limited is an India-based pharmaceutical company. The Company operates through the manufacture of pharmaceutical formulation segment. The Company is primarily engaged in the research, manufacturing and marketing of generic pharmaceutical formulations with three state-of-the-art facilities in India, the United Kingdom and the United States. It marks its presence across different therapeutic areas in the region, such as pain management, diabetes, cough and cold...
Mark Saldanha
Executive Non-Independent Chairman of the Board, Managing Director
Address
21 Lotus Business Park
, Off New Link Road,, Andheri (W)
Mumbai
400053
India